Quarta-Rad is a small company transitioning from a legacy radiation detection equipment business to an AI-driven call center software business through its wholly owned subsidiary, Sellavir. The legacy business — which sold Geiger counters and similar radiation detection devices to consumers via the internet and third-party resellers — is being wound down and is no longer expected to generate meaningful revenue. Sellavir's core product is CenterEye, a call center software platform that uses AI and machine learning to analyze audio, video, and performance data in real time, helping call centers improve agent performance, automate parts of call handling, and improve the customer experience. CenterEye targets enterprise operators running call centers on major cloud-based platforms, including Genesys Cloud, NICE CXone, and Avaya. In January 2026, Sellavir signed an ISV Partner Agreement with Genesys Cloud, allowing CenterEye to integrate into that platform — the first step toward commercialization. Sellavir intends to generate revenue through software licensing and service agreements in a SaaS-style model. The product is still in development and has not yet generated significant revenue. Quarta-Rad currently has no full-time employees, operates with part-time executive leadership, and has insufficient cash on hand to cover the next 12 months of operating expenses, raising going concern doubt.
Read full business overview →Mid to long-term bullish thesis
View →Mid to long-term bearish thesis
View →Mid to long-term bull-bear debate
View → NEWSummary and scoring of the bull-bear debate
View →Find ideas with similar bull or bear theses
View →Investor-relevant company attributes
View →Key risks to the business
View →Comparisons of annual risk disclosures
View →